D. W. Shinta, J. Khotib, E. Rahardjo, M. Rahmadi, and B. Suprapti, “THE USE OF HYDROXYETHYL STARCH 200/0,5 AS PLASMA SUBTITUTES IS SAFE IN HYPOVOLEMIC PATIENTS AS INDICATED IN CHANGES OF N-ACETYL--GLUCOSAMINIDASE AND CREATININ SERUM PARAMETERS”, FMI, vol. 51, no. 4, pp. 228–233, Dec. 2015.